Prolongation of adenoviral transgene expression in mouse liver by T lymphocyte subset depletion

Gene Therapy

Volumn 3, Issue 1, 1996, Pages 4-12

  DeMatteo, R P ^a   Markmann, J F ^a   Kozarsky, K F ^a   Barker, C F ^a   Raper, S E ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

gene therapy; immunologic tolerance; recombinant adenovirus

Indexed keywords

ADENOVIRUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; HISTOLOGY; IMMUNOLOGICAL TOLERANCE; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENE; VIRUS RECOMBINANT;

ADENOVIRUSES, HUMAN; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELL LINE; CELLS, CULTURED; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HELA CELLS; HUMANS; LAC OPERON; LIVER; LYMPH NODES; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; THYMECTOMY; TIME FACTORS;

EID: 0029991196     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Stratford-Perricaudet LD et al. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum Gene Ther 1990; 1: 241-256.
2. Yang Y et al. An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. Proc Natl Acad Sci USA 1993; 90: 4601-4605.
3. Barr D et al. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Therapy 1995; 2: 151-155.
4. Yang Y et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91: 4407-1411.
5. Yang Y et al. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet 1994: 7: 362-369.
6. Engelhardt JF, Ye X, Doranz B, Wilson JM. Ablation of E2a in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 1994; 91: 6196-6200.
7. Engelhardt JF et al. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nat Genet 1993; 4: 27-34.
8. Kass-Eisler A et al. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Therapy 1994; 1: 395-402.
9. Cobbold SP et al. Reprogramming the immune system for peripheral tolerance with anti-CD4 and CD8 monoclonal antibodies. Immunol Rev 1992; 129: 165-201.
10. Goss JA, Finke EH, Flye MW, Lacy PE. Induction of immune unresponsiveness to concordant islet xenografts by intrahepatic preimmunization and transient immunosuppression. J Clin Invest 1994; 93: 1312-1314.
11. Alters SE et al. Anti-CD4 mediates clonal anergy during transplantation tolerance induction. J Exp Med 1991; 173: 491-494.
12. Benjamin RJ, Waldmann H. Induction of tolerance by monoclonal antibody therapy. Nature 1986; 320: 449-451.
13. Biasi G et al. Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice. J Immunol 1991; 147: 2284-2289.
14. Waldor MK et al. Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science 1985; 227: 415-417.
15. Ramsdell F, Fowlkes BJ. Maintenance of in vivo tolerance by persistence of antigen. Science 1992; 257: 1130-1134.
16. Qin S et al. 'Infectious' transplantation tolerance. Science 1993; 259: 974-977.
17. Erlich KS, Mills J, Shanley JD. Effects of L3T4+ lymphocyte depletion on acute murine cytomegalovirus infection. J Gen Virol 1989; 70: 1765-1771.
18. Kadima-Nzuji M, Craighead JE. T-tymphocyte effects on murine cytomegalovirus pulmonary infection. Am J Pathol 1990; 137: 907-912.
19. Brody AR, Craighead JE. Pathogenesis of pulmonary cytomegalovirus infection in immunosuppressed mice. J Infect Dis 1974; 129: 677-689.
20. Yang Y, Ertl HCJ, Wilson JM. MHC Class-1 restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1994; 1: 433-442.
21. Ginsberg HS et al A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci USA 1991; 88: 1651-1655.
22. Leist TP et al. Functional analysis of T lymphocyte subsets in antiviral host defense. J Imunol 1987; 138: 2278-2281.
23. Penna A et al. Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTLs that recognize endogenously synthesized HBV envelope antigens. J Virol 1992; 66: 1193-1198.
24. Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature 1994; 367: 425-428.
25. Goronzy J, Weyand CM, Fathman CG. Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4. J Exp Med 1986; 164: 911-925.
26. Yei S et al. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Therapy 1994; 1: 192-200.
27. Ando K et al. Mechanisms of class 1 restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med 1993; 178: 1541-1554.
28. Rosenberg AS, Munitz TI, Maniero TG, Singer A. Cellular basis of skin allograft rejection across a Class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo. J Exp Med 1991; 173: 1463-1471.
29. + cytolytic T cells. Nature 1990; 344: 742-746.
30. Connolly K, Roubinian JR, Wofsy D. Development of murine lupus in CD4-depleted NZB/NZW mice. J Immunol 1992; 149: 3083-3088.
31. + helper cells. Nature 1987; 328: 77-79.
32. DeMatteo RP, Markmann JF, Raper SE. An improved technique of thymectomy in the adult mouse. Transplantation 1995; 59: 787-789.
33. Wilde DB et al. Evidence implicating L3T4 in Class II MHC antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a) blocks Class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines. J Immunol 1983; 131: 2178-2183.
34. Ledbetter JA, Herzenberg LA. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 1979; 47: 63-90.
35. Markmann JF et al. Modulation of the major histocompatibility complex antigen and the immunogenicity of islet allografts. Transplantation 1989; 48: 478-486.